Live Breaking News & Updates on Kimn Chi

Stay updated with breaking news from Kimn chi. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Olaparib combo improves PFS in metastatic prostate cancer

Frontline olaparib plus abiraterone/prednisone combo improves survival in patients with metastatic castration-resistant prostate cancer. ....

United Kingdom , British Columbia , United States , Maha Hussain , Kimn Chi , Roberth Lurie Comprehensive Cancer Center , Prostate Cancer Working Group , University Of British Columbia , Comprehensive Cancer Center , Both Dr Hussain , Prostate Carcinoma , Alignant Prostate Neoplasm , Prostate Cancer , Ancer Of The Prostate , Breast Cancer , Alignant Breast Neoplasm , Breast Carcinoma , Alignant Neoplasia , Alignant Neoplasm , Ovarian Cancer Malignant Neoplasm , Ovary Cancer , Genomics Genomic Medicine , Parp Inhibitors , Parp Inhibition , Oly Adp Ribose Polymerase Inhibitor ,

Small PFS Gain in Metastatic Prostate Cancer With TKI, ICI

Men with metastatic castration-resistant prostate cancer had a slight but significant improvement in progression-free survival with a TKI plus immunotherapy vs hormonal therapy. ....

United States , University Of Utah , United Kingdom , Salt Lake City , British Columbia , Kimn Chi , Neeraj Agarwal , Kim Chi , Xin Gao , Prostate Cancer Working Group , University Of British Columbia , Cancer Center , Huntsman Cancer Institute , Salt Lake , Mass General Cancer Center , Prostate Carcinoma , Alignant Prostate Neoplasm , Prostate Cancer , Ancer Of The Prostate , Hormone Therapy , Hormonal Therapy , Etastatic Carcinoma , Metastatic Cancer , Biologic Therapy , Hepatocellular Carcinoma Hcc Liver Cancer Of The ,

Cabozantinib Plus Atezolizumab Delays Progression in mCRPC

Combination improved PFS versus more hormonal therapy, but control arm questioned ....

United States , United Kingdom , British Columbia , Salt Lake City , University Of Utah , Mike Bassett , Neeraj Agarwal , Kimn Chi , British Columbia Cancer Agency , Huntsman Cancer Institute , Genitourinary Cancers ,

Olaparib-Abiraterone in Biomarker-Selected mCRPC Tops Each Agent Alone

In small first-line trial, PFS more than doubled with combination ....

United States , British Columbia , United Kingdom , Maha Hussain , Mike Bassett , Kimn Chi , Northwestern University Feinberg School Of Medicine , British Columbia Cancer Agency , Northwestern University , Feinberg School , Genitourinary Cancers Symposium ,

Dr Chi on the MAGNITUDE Trial of Niraparib Plus Abiraterone in BRCA-Mutated mCRPC

Kim N. Chi, MD, FRCPC, discusses data from the updated and final analysis of the phase 3 MAGNITUDE trial in BRCA-positive metastatic castration-resistant prostate cancer. ....

United Kingdom , Kimn Chi , University Of British Columbia , Division Of Medical Oncology , Medical Oncology , British Columbia , Prostate Cancer , Phase 3 Magnitude Nct03748641 ,